The Bexley restaurants, cafes and takeaways with poor food hygiene
Of these venues, two received a score of 1 out of 5 during inspections since January, meaning that major improvements are necessary.
Three places scored a 2/5, meaning 'improvement necessary.'
Inspectors from Bexley Council's environmental health have not slammed any restaurants and cafes with the lowest possible score, a 0/5, meaning that 'urgent improvement necessary," this year.
We have listed these places and the date their rating was given.
It's important to note that this list is only about Bexley restaurants, coffee shops, and cafes, and did not feature anything the health departments count as takeaways or sandwich shops.
Low hygiene ratings in Bexley (Feb–Jul 2025)
Rated 1 – Major improvement necessary
Beirut City Lebanese, 222 Broadway, Bexleyheath – inspected January 22
Crayford Tandoori Restaurant, 4 Waterside, Crayford – inspected May 14
Inspectors deemed the management of food safety in both of these restaurants as needing 'major improvement'.
Rated 2 – Some improvement necessary
F & D's Café, 6 Bellegrove Parade, Welling – inspected May 14
Jalsha Tandoori, 169-171 Station Road, Sidcup – inspected June 23
Three Cooks Sandwich Bar, 66 Nuxley Road, Belvedere – inspected May 28
A food safety officer will focus on three key areas during their inspection.
These areas are the hygienic food handling, cleanliness and condition of facilities and buildings, and the management of food safety.
A low hygiene rating doesn't automatically mean a restaurant is unsafe, but it does indicate that standards have fallen below what is expected.
Businesses receiving a 1 or 2 are expected to make improvements quickly and may be subject to follow-up visits or further action from the local authority.
If necessary changes aren't made, the council can take enforcement action, which could include fines, closure notices, or even prosecution.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
35 minutes ago
- Yahoo
‘Systemic failures' led to unlawful death of girl at mental health unit
The parents of a teenage girl who died after being left alone at a children's mental health ward by an agency worker using a fake ID have said 'systemic failures' led to her unlawful death. Ruth Szymankiewicz was being treated for an eating disorder at Huntercombe Hospital in Berkshire and had been placed under strict one-to-one observation when on February 12 2022, she was left on her own by the member of staff responsible for watching her. The 14-year-old was able to shut herself in her bedroom at the hospital's psychiatric intensive care unit – also known as Thames ward – where she self-harmed. She died two days later at John Radcliffe Hospital in Oxford. On Thursday, an inquest jury sitting at Buckinghamshire Coroner's Court in Beaconsfield returned a conclusion of unlawful killing. Speaking outside the court after the hearing, Mark and Kate Szymankiewicz said: 'When, at our most vulnerable as a family, we reached out for help; we ultimately found ourselves trapped in a system that was meant to care for her, to help her, to keep her safe, but instead locked her away and harmed her. 'Having been detained in a unit she should never have been sent to, Ruth was repeatedly denied access to the love and support of her family. 'We were excluded and completely disempowered. She was isolated, scared and alone.' Mark, a consultant surgeon, and Kate, a GP, added: 'Over the last two weeks, we have heard about the numerous systemic failures at Huntercombe Hospital. 'Ruth was our daughter. But she could just as easily be your child, your niece or nephew, your grandchild. 'We hope that by sharing her story it can help inform the change needed in children's mental health services.' During the conclusion hearing on Thursday, the jury foreman told the court: 'Ruth was not prevented from accessing the restricted material which could be used to self-harm.' 'Ruth was not prevented from accessing harmful material on the internet. 'Ruth's care pathway… was insufficient to allow improvement for discharge. 'From Ruth's admission to Thames ward, her responsible clinician deemed the ward to be neither suitable nor conducive to her recovery. 'Ruth's parents were not given adequate information about the appeal process, and refusal rights.' Jurors could be seen crying as they recorded their conclusion, as well as the coroner and members of the family. The agency worker responsible for watching Ruth – a man then known as Ebo Acheampong – had never worked in a psychiatric hospital environment before coming to Huntercombe on February 12 2022 for his first shift. A police investigation later found he was hired by the Platinum agency – which supplied staff for Huntercombe Hospital – under a false name. Mr Acheampong never returned to work at the hospital following the incident and fled the UK for Ghana. The court heard the ward was missing at least half of its staff on the day Ruth, who had self harmed several times in the past, was left unsupervised. Mr Acheampong was originally working on a different ward, but was asked to join the team on Thames ward because they were so short-staffed nurses could not go on breaks, jurors were previously told. A risk management form known as a 'Datix incident' had been filed on the day by Michelle Hancey – a support worker with 18 years' experience at Huntercombe – who raised concerns the Thames ward team would 'fail to monitor patients on prescribed special observation because of staff shortage'. During the inquest, jurors were shown CCTV footage of the moment Mr Acheampong left Ruth unsupervised while she sat in the ward's lounge watching TV, enabling her to leave the room. She had been placed on the 'level three observation' plan following earlier incidents of self-harm – meaning she had to be kept within eyesight at all times. In the footage, Mr Acheampong can be seen leaving the room repeatedly – at first only for seconds at a time, then for two minutes – prompting the teenager to walk up to the door and look into the lobby, seemingly waiting for the opportunity to leave the room. She was last captured on CCTV walking out of the ward's day room 'completely on her own' before going straight to her bedroom and closing the door behind her, coroner Ian Wade KC told the inquest. Around 15 minutes passed before a nurse discovered the teenage girl and raised the alarm. Huntercombe Hospital had been inspected twice by the Care Quality Commission (CQC) prior to the incident, the inquest previously heard. It was rated as 'overall inadequate' in a CQC report dated February 2021. Active Care Group, which owned Huntercombe at the time of Ruth's death, has since closed the facility. Following the inquest, a spokesperson said: 'We extend our heartfelt condolences to Ruth's family, friends, and all those affected by her passing. 'We deeply regret the tragic event that occurred, and we are truly sorry for the distress this has caused and recognise the profound impact it has had on everyone who knew her. 'In recent years, we have made significant improvements to the quality and safety in all of our services. 'We remain fully committed to working closely with our teams across the country to ensure consistently high standards of care for the individuals we support. 'We are dedicated to learning any further lessons through both this inquest process and others from across the NHS and Independent sector with the aim of preventing any future tragic incidents.'
Yahoo
an hour ago
- Yahoo
Lilly to hike UK price of Mounjaro weight-loss drug by 170%
By Maggie Fick SEATTLE (Reuters) -Eli Lilly will raise the UK list price of its weight-loss treatment Mounjaro by up to 170%, it said on Thursday, amid a White House push to get drugmakers to raise medicine prices in Europe to allow for price cuts in the United States. The new price, which also applies to Lilly's type 2 diabetes medicine that has the same name, is effective from September. The price for a month's supply of the highest dose of the medicine will increase from £122 to £330, Lilly said. The higher price will affect those who pay for Mounjaro privately, but will not affect those prescribed the medicine through the British public healthcare system, which has a separate deal, a Lilly spokesperson said. The U.S. drugmaker said that when it launched Mounjaro in Britain it agreed to a list price "significantly below" that in its three other European markets to prevent delays in availability through Britain's National Health Service (NHS). "We are now aligning the list price more consistently," Lilly said. The move reflects how the pharmaceutical industry is navigating policy changes in the United States, by far its most lucrative market, where President Donald Trump is pushing for lower domestic prices and encouraging price hikes overseas. Last week Eli Lilly CEO David Ricks told an investor call that parity between U.S. and European drug pricing was desirable in the long run, though he warned that European governments "are not signing up to pay more for drugs". The U.S. pays more for prescription drugs than any other country, often nearly three times as much as other developed nations. Trump says he wants to narrow this gap to stop Americans from being "ripped off." Reuters reported last week that the Trump administration has been talking to drugmakers about ways to level the playing field for medicine prices. A list price is set by the drug manufacturer before any rebates or discounts. Lilly said it was working with private UK healthcare providers, such as online pharmacies, who can set their own prices, to ensure continued access to the medicines. Lilly launched Mounjaro in the UK in February last year, while rival Novo Nordisk's Wegovy treatment has been available in the country since September 2023.
Yahoo
an hour ago
- Yahoo
Inquiry into rogue surgeon to hold preliminary hearing next month
A public inquiry set up to investigate disgraced surgeon Sam Eljamel will hold a preliminary hearing next month. The Eljamel Inquiry will investigate the activities and oversight of Mr Eljamel, who was appointed by NHS Tayside as a consultant neurosurgeon at Ninewells Hospital in Dundee in 1995 and went on to become head of neurosurgery at the site. In 2013, Mr Eljamel was placed under supervision and later suspended following concerns about the standard of clinical care he was providing to patients. He resigned from NHS Tayside in 2014. Patients of the former neurosurgeon have claimed he harmed as many as 200 people, with some suffering life-changing injuries. The Eljamel Inquiry will determine, among other things, whether patients were let down by failures in clinical governance, risk management, and complaints procedures, and the adequacy of previous reviews. It will also examine to what extent Mr Eljamel's private practice, research, and workload impacted on care received by his patients, and whether, and if so to what extent, Mr Eljamel and NHS Tayside tried to conceal evidence of sub-standard care. The independent public inquiry, chaired by Lord Weir, will hold a preliminary hearing in Edinburgh on September 10 to set out its progress and intentions. Scotland's Health Secretary Neil Gray formally set up the inquiry on April 3, empowering it to begin the process of gathering evidence. To date, Lord Weir has designated applicants including NHS Tayside, 133 former patients of Mr Eljamel and 19 personal representatives of former patients. This group is represented by the legal firm Levy & McRae. The Scottish Government and the University of Dundee are also designated as core participants, as are the Royal College of Surgeons (Edinburgh), Healthcare Improvement Scotland, and NHS Education for Scotland. Members of the public, including former patients, can apply to attend the preliminary hearing in person. Proceedings will also be broadcast live on the inquiry's YouTube channel, and will be available to view later on its website. The preliminary hearing will take place at Waverley Gate in central Edinburgh.
